{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_14604", "batch_size": 217, "batch_pos": 91, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral language about procurement ('secures up to', 'includes an option').", "method": "llm_batch", "batch_id": "batch_2_17240", "batch_size": 189, "batch_pos": 68, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "No moderate verb paired with significant scale/impact.", "method": "llm_batch", "batch_id": "batch_3_6400", "batch_size": 122, "batch_pos": 6, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment is a statement, not a question.", "method": "llm_batch", "batch_id": "batch_4_17188", "batch_size": 260, "batch_pos": 250, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment reports factual information but lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_15168", "batch_size": 260, "batch_pos": 248, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found. 'up to' and '40 million' are not minimisers.", "method": "llm_batch", "batch_id": "batch_6_16508", "batch_size": 260, "batch_pos": 209, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation pattern as defined by Q7.", "method": "llm_batch", "batch_id": "batch_7_14976", "batch_size": 260, "batch_pos": 193, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes securing doses ('deal secures up to 665,000 doses') and options ('includes an option for a further 40 million vaccines') which are preparedness statements without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_15052", "batch_size": 125, "batch_pos": 20, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
